HOME ABOUT US ADVERTISE SUBSCRIBE SITE MAP HELP CONTACT WORK FOR US  
Tuesday
9 February 2010
Make BTN my HomePage 
 
   TODAY'S STORIES
 
PROFESSIONAL PLACEMENTS 
Senior Government Affairs Adviser
(Monday, 1 February 2010)

“…outstanding opportunity to make a significant impact with global market leader…”
Full Story...


Database Administrator
(Tuesday, 19 January 2010)

  • Several databases (proprietary application)
  • Immediate start
  • New single database launch in mid 2010
  • Malvern based

    • Full Story...


    Policy Manager
    (Monday, 18 January 2010)

  • Biotechnology Focus
  • Advocacy
  • Government Liaison
  • Melbourne Based – Part Time

    • Full Story...



    GOVERNMENT BUSINESS 
    FDA meeting troubles and delays for ChemGenex, shares bomb
    (Tuesday, 9 February 2010)

    CHEMGENEX will have to answer some tough questions when it faces the FDA’s Oncologic Drugs Advisory Committee – but not tomorrow, as planned, as wild weather in the US has forced the regulator to delay its planned meeting to consider the fate of chronic myeloid leukaemia drug Omapro.
    Full Story...


    MORE GOVERNMENT BUSINESS

    CRC info sessions looming


    2010 NHMRC Australia Fellowships awarded


    WA frees up GM crop rules


    VIEW ALL STORIES

    AGRICULTURAL BIOTECH 
    Termite oil gets the tick
    (Tuesday, 9 February 2010)

    NATURAL product developer BioProspect has secured government approval for an oil used as an active ingredient in its Termilone termite solution.
    Full Story...


    MORE AGRICULTURAL BIOTECH

    WA frees up GM crop rules


    Merial reworking Imugene agreement


    VIEW ALL STORIES

    HEALTH BIOTECH 
    Cochlear notches up $75.2M profit
    (Tuesday, 9 February 2010)

    HEARING implant provider Cochlear has good news for investors – it had net profit after tax of $A75.2 million and will pass earnings on to shareholders with a dividend.
    Full Story...


    MORE HEALTH BIOTECH

    FDA meeting troubles and delays for ChemGenex, shares bomb


    New Pharmaxis drug clears Phase 1


    OPINION: Patient safety should be priority in stem cell decisions


    VIEW ALL STORIES

    INDUSTRIAL BIOTECH 
    Stability, funding for PolyNovo
    (Tuesday, 12 January 2010)

    CALZADA (formerly Metabolic) has pushed back plans to spin out PolyNovo, making an offer to the company’s other major shareholders for their holdings and committing to fund the biomaterial company’s development for at least the next 12 to 24 months.
    Full Story...


    INDUSTRY ISSUES 
    OPINION: Patient safety should be priority in stem cell decisions
    (Tuesday, 9 February 2010)

    STEM cell treatments have become one of the great medical promises of the age. But even though most of the treatments now being offered commercially are unproven, Australians are flocking to overseas stem cell “clinics” in search of a miracle cure. The Australian Stem Cell Centre’s Dr Kirsten Herbert sounds a warning to the local industry and to journalists covering the subject.
    Full Story...


    MORE INDUSTRY ISSUES

    Secondary financing back at '07 levels: PwC


    OPINION: An inside guide to a successful biotech IPO


    VIEW ALL STORIES



    		 


    Cochlear notches up $75.2M profit
    (Tuesday, 9 February 2010)

    HEARING implant provider Cochlear has good news for investors – it had net profit after tax of $A75.2 million and will pass earnings on to shareholders with a dividend.
    Full Story...


    FDA meeting troubles and delays for ChemGenex, shares bomb
    (Tuesday, 9 February 2010)

    CHEMGENEX will have to answer some tough questions when it faces the FDA’s Oncologic Drugs Advisory Committee – but not tomorrow, as planned, as wild weather in the US has forced the regulator to delay its planned meeting to consider the fate of chronic myeloid leukaemia drug Omapro.
    Full Story...


    New Pharmaxis drug clears Phase 1
    (Tuesday, 9 February 2010)

    PHARMAXIS’ early-stage pipeline has received a boost, with the next cab off the company’s drug ranks clearing its first Phase 1 trial. Pharmaxis announced results from the 40-patient trial on pulmonary fibrosis drug PXS25 this morning, saying the drug is “safe and well tolerated”.
    Full Story...

       

    AusBiotech

    Government’s R&D tax credit draft legislation needs to meet policy intent

    AusBiotech joins PwC to webcast an update on biotech performance

    Tax changes to employee share schemes: bills passed

    Independent study confirms ‘intangible’ benefits of AusBiotech national conference

    Chance to learn from world-leading valuation expert






       TODAY'S STORIES CONTINUED


    OPINION: Patient safety should be priority in stem cell decisions
    (Tuesday, 9 February 2010)

    STEM cell treatments have become one of the great medical promises of the age. But even though most of the treatments now being offered commercially are unproven, Australians are flocking to overseas stem cell “clinics” in search of a miracle cure. The Australian Stem Cell Centre’s Dr Kirsten Herbert sounds a warning to the local industry and to journalists covering the subject.
    Full Story...

    Termite oil gets the tick
    (Tuesday, 9 February 2010)

    NATURAL product developer BioProspect has secured government approval for an oil used as an active ingredient in its Termilone termite solution.
    Full Story...

    CBIO prepares for ASX debut
    (Tuesday, 9 February 2010)

    CBIO is set to become the first life science company to close an initial public offering since the float of Fluorotechnics in October 2008.
    Full Story...

    Relenza royalties up for Biota
    (Tuesday, 9 February 2010)

    MELBOURNE-based Biota expects a 35.3% jump in Relenza royalties for the December quarter after GlaxoSmithKline revealed quarterly sales hit $A462 million.
    Full Story...

    Mimotopes wins QIMR contract for malaria screening
    (Tuesday, 9 February 2010)

    LOCAL Commonwealth Biotechnologies subsidiary Mimotopes has signed a major contract with the Queensland Institute of Medical Research to supply a peptide library, which the institute will use to screen for potential malaria vaccine compounds.
    Full Story...

    Bio Briefs: LCT, CSL, Probiotec and Analytica
    (Tuesday, 9 February 2010)

    LIVING Cell Technologies has taken a 10% stake in US wound-healing company CytoSolv in exchange for supplying choroid plexus cell clusters from its New Zealand-based pathogen-free pig herd.
    Full Story...

    Benitec technology ‘validated’ by Pfizer-Tacere deal
    (Tuesday, 9 February 2010)

    BENITEC received a boost last week on news that global pharmaceutical giant Pfizer has exercised a $US145 million option with Benitec spin-off Tacere Therapeutics for the development of hepatitis C virus compounds which use Benitec technology.
    Full Story...

    Market Pulse: Not happy, Jan
    (Monday, 8 February 2010)

    BIOTECH stocks were hammered with the rest of the market at the back end of the week. Despite a positive start, the ASX fell sharply late last week, with Thursday and Friday a sea of red on the boarse.
    Full Story...

    Positive trends, but Avexa misses primary Phase 3 endpoint
    (Thursday, 4 February 2010)

    AVEXA will be forced to rely on secondary efficacy data to attract a partner for HIV drug ATC, after the headline data from the abbreviated Phase 3 trial of the drug showing the trial’s early close prevented it from demonstrating clinical significance in the trial’s primary endpoint.
    Full Story...

    Phosphagenics nears local launch of cosmeceutical range
    (Thursday, 4 February 2010)

    PHOSPHAGENICS has signed up eastern states pharmacy chain Pulse Pharmacies as the exclusive distributor of its new Elixia skincare product range.
    Full Story...

    Antisense takes off on patent announcement
    (Thursday, 4 February 2010)

    ANTISENSE has become the latest biotech company to see its shares take off on a relatively minor announcement, with its shares quadrupling yesterday on massive volumes.
    Full Story...


    USER INFO
    Welcome to BTN
    (GUEST)

      Click here to login
      Sign up today
      Manage Members


    Company Search




    Story Search

    Advanced Search


    UPCOMING
    EVENTS
    BioMelbourne Network BioBreakfast
    Fast Start your Biotechnology Project Management Skills Course (SA,WA, NSW, QLD)
    31st Lorne Genome conference
    Clever Green Conference & Showcase
    Energising WA Branch Biotech Breakfast Series
    Baker & McKenzie Life Sciences Conference: Topical Issues with a Global Impact
      View all events



    ONLINE AND PRINT PUBLICATIONS
    Miningnews.net
    Mining industry news leader
    MiningNewsPremium.net
    Premium mining news coverage
    PetroleumNews.net
    Online oil & gas industry news
    International
    Longwall News
    Longwall mining's news source
    Construction
    IndustryNews.net
    Essential construction industry news
    WME Environmental
    Management News.net
    Essential environmental management news
    BiotechnologyNews.net
    Essential biotechnology news for smart investors
    PNGIndustryNews.net
    Essential PNG industry news
    SuperLiving.com.au
    Live and Invest with Attitude!
    SearchMining.net
    The search engine for the mining industry
    SearchPetroleum.net
    The search engine for the oil and gas industry
    SearchConstruction.net
    The search engine for the construction industry
    SearchSupplyChain
    Logistics.net
    The search engine for the supply chain and logistics industry
     

    Australia's Mining Monthly
    Powerful. Reliable.
    RESOURCESTOCKS
    Australia's resources investment magazine
    Australian Longwall
    Essential reading for longwall industry
    Coal USA magazine
    Inside the longwall and room & pillar industries
    International-China Mining Review
    CONTRACTOR
    Australia's construction and earthmoving magazine
    Cranes and Lifting Australia
    The voice of the cranes and lifting industy
     

    INDUSTRY NEWS PORTAL
    IndustryNews.net
    Portal to Aspermont’s leading publications